Trial Profile
Prospective Randomized Controlled, Open Label, Clinical Trial to Study if Rosuvastatin Use Improves the Coagulation Profile in Patients With Venous Thrombosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Venous thromboembolism; Venous thrombosis
- Focus Pharmacodynamics
- Acronyms START
- 30 Jan 2018 Results (n=255) assessing whether statin therapy improves the coagulation profile in patients with a history of VT, were published in the European Heart Journal.
- 13 Jan 2017 Status changed from recruiting to completed.
- 20 Apr 2016 Interim results (n=50) published in the Journal of Thrombosis and Haemostasis